3D Systems
3D Systems has announced changes in the company’s leadership structure. Reji Puthenveetil, who currently serves as EVP, Industrial Solutions, will take on expanded responsibilities as EVP, Additive Solutions and Chief Commercial Officer. Menno Ellis and Andy Johnson are both leaving the company.
In Puthenveetil’s new role, he will have responsibility for all of the company’s commercial operations, ranging from Sales and Marketing to 3D Systems Application Innovation Group,, across both the Industrial and Healthcare business units.
With the consolidation of commercial responsibilities, Menno Ellis, who has served as the leader of the company’s Healthcare business from its creation in 2020, will be leaving the company to pursue other leadership opportunities.
The company will continue to operate two business units, Healthcare Solutions, comprising both Medical Devices and Dental markets, and Industrial Solutions, which spans multiple industrial market verticals, from aerospace and defence to semiconductor, automotive, energy, and consumer markets.
Read more:
3D Systems appoints new CFO & creates new position of President – Regenerative Medicine
3D Systems set to reduce debt by nearly 30% with partial repurchase of Convertible Senior Notes
3D Systems remains keen on Stratasys merger after Desktop Metal deal is vetoed by shareholders
Andy Johnson, Chief Corporate Development Officer and Chief Legal Counsel, who has served the company for 17 years, will be leaving to pursue new leadership opportunities. Andy will remain in his role while a search is undertaken for a new General Counsel.
“We are grateful to both Menno and Andy for their many contributions to the company. Since my arrival in the summer of 2020, both leaders have been instrumental in helping focus and reshape the company, as we have transformed into the two distinct business units we have today. I am confident that both executives will continue to find great success in their future leadership endeavours,” said Jeffrey Graves, President and Chief Executive Officer.
Graves added: “This simplification of our commercial operations will support optimisation of our go-to-market strategies, reduce operating costs, and enhance our ability to respond quickly to changes in the market as momentum continue to build in the adoption of 3D printing in production facilities around the world. Importantly, by continuing to operate in two business units, we will retain a strong focus on the unique needs of both our Healthcare and Industrial customers, an approach that has been very well received in the market.”
